Xelan

Exelan Pharmaceuticals is a specialty pharmaceutical company based in the United States and a subsidiary of the global pharmaceutical firm Cipla. The company focuses on the sales and marketing of generic pharmaceutical products, primarily serving the U.S. federal government and institutional markets, including the Department of Veterans Affairs (VA) and the Department of Defense (DOD). Exelan's portfolio encompasses a broad range of therapeutic categories such as cardiovascular, central nervous system, and anti-infectives, providing high-quality, affordable medicines to veterans and active military personnel. Since its acquisition by Cipla in 2015, Exelan has leveraged its parent company's global manufacturing and R&D capabilities to expand its presence in the U.S. generic drug market.